Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Aarti Drugs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:524348NSE Symbol: AARTIDRUGSP/E(TTM):30.55
ISIN Demat:INE767A01016Div & Yield %:0.19EPS(TTM):17.11
Book Value(Rs):136.1848045Market Cap ( Cr.):4804.98Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 2266.912497.972251.171914.891634.921454.25
Excise Duty0.000.000.000.000.000.00
Net Sales2266.912497.972251.171914.891634.921454.25
Other Income 4.182.234.779.699.446.28
Stock Adjustments -26.776.7277.949.0853.94-19.05
Total Income2244.322506.922333.881933.661698.301441.48
EXPENDITURE :      
Raw Materials 1476.421723.251558.471148.991099.82945.98
Power & Fuel Cost151.64153.45126.0595.64101.0482.14
Employee Cost 70.2064.3057.1755.6052.6547.23
Other Manufacturing Expenses 191.24182.71171.26138.99122.62103.91
Selling and Administration Expenses 73.9589.2589.7576.7059.3950.37
Miscellaneous Expenses 7.525.685.246.725.402.83
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1970.962218.642007.951522.641440.921232.46
Operating Profit273.36288.28325.94411.02257.38209.02
Interest 33.2136.1823.0525.7135.7441.00
Gross Profit240.15252.10302.89385.31221.64168.02
Depreciation47.6747.2947.3947.6046.6740.39
Profit Before Tax192.48204.81255.50337.71174.97127.63
Tax49.6053.2565.5084.5049.5531.92
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax1.00-1.25-5.00-4.50-10.258.45
Reported Net Profit141.88152.81195.00257.71135.6787.26
Extraordinary Items 0.000.000.000.176.352.54
Adjusted Net Profit141.88152.81195.00257.54129.3284.72
Adjst. below Net Profit -13.320.00-51.64-69.90-26.90-0.48
P & L Balance brought forward947.13818.86704.26565.52475.07399.36
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 23.3824.5428.7649.0718.3211.06
P & L Balance carried down1052.31947.13818.86704.26565.52475.07
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %10.0010.0010.0025.0020.0010.00
Earnings Per Share-Unit Curr15.4316.5021.0627.6558.2337.00
Earnings Per Share(Adj)-Unit Curr15.4316.5021.0627.6514.569.25
Book Value-Unit Curr127.83120.34104.9992.23266.86219.90